Implantable cardioverter defibrillators in octogenarians: clinical outcomes from a single center.

PubWeight™: 0.82‹?›

🔗 View Article (PMC 4380689)

Published in Indian Pacing Electrophysiol J on April 01, 2015

Authors

D G Wilson1, N Ahmed2, R Nolan2, A Frontera2, G Thomas2, E R Duncan2

Author Affiliations

1: University Hospital Southampton NHS Foundation Trust, Tremona Road, Southampton, SO16 6YD.
2: Bristol Heart Institute, University Bristol Hospitals NHS Foundation Trust, Malborough street, Bristol BS6 8HW.

Articles cited by this

Amiodarone or an implantable cardioverter-defibrillator for congestive heart failure. N Engl J Med (2005) 27.36

Non-evidence-based ICD implantations in the United States. JAMA (2011) 5.05

Current burden of sudden cardiac death: multiple source surveillance versus retrospective death certificate-based review in a large U.S. community. J Am Coll Cardiol (2004) 4.44

Canadian implantable defibrillator study (CIDS) : a randomized trial of the implantable cardioverter defibrillator against amiodarone. Circulation (2000) 4.12

2013 ESC guidelines on cardiac pacing and cardiac resynchronization therapy: the task force on cardiac pacing and resynchronization therapy of the European Society of Cardiology (ESC). Developed in collaboration with the European Heart Rhythm Association (EHRA). Europace (2013) 4.07

Randomized comparison of antiarrhythmic drug therapy with implantable defibrillators in patients resuscitated from cardiac arrest : the Cardiac Arrest Study Hamburg (CASH). Circulation (2000) 3.98

Prospective study of sudden cardiac death among women in the United States. Circulation (2003) 3.45

Meta-analysis: age and effectiveness of prophylactic implantable cardioverter-defibrillators. Ann Intern Med (2010) 2.46

Survival after implantable cardioverter-defibrillator implantation in the elderly. Circulation (2013) 2.30

Implantable cardioverter-defibrillator prescription in the elderly. Heart Rhythm (2009) 1.88

Use of implantable cardioverter-defibrillators for primary prevention in older patients: a systematic literature review and meta-analysis. Cardiol J (2011) 1.50

Improved survival associated with prophylactic implantable defibrillators in elderly patients with prior myocardial infarction and depressed ventricular function: a MADIT-II substudy. J Cardiovasc Electrophysiol (2007) 1.26

Applicability of a risk score for prediction of the long-term (8-year) benefit of the implantable cardioverter-defibrillator. J Am Coll Cardiol (2012) 1.23

Factors associated with pulseless electric activity versus ventricular fibrillation: the Oregon sudden unexpected death study. Circulation (2010) 1.17

Implantable cardioverter-defibrillators should be used routinely in the elderly. Am J Geriatr Cardiol (2006) 1.13

Predictors of long-term mortality in Multicenter Automatic Defibrillator Implantation Trial II (MADIT II) patients with implantable cardioverter-defibrillators. Heart Rhythm (2008) 1.10

Prophylactic implantable cardioverter-defibrillator treatment in the elderly: therapy, adverse events, and survival gain. Europace (2011) 0.97

End-of-life care in patients with implantable cardioverter defibrillators: a MADIT-II substudy. Pacing Clin Electrophysiol (2013) 0.88

Causes and prevention of sudden cardiac death in the elderly. Nat Rev Cardiol (2013) 0.85

Association between myocardial substrate, implantable cardioverter defibrillator shocks and mortality in MADIT-CRT. Eur Heart J (2013) 0.85

Implantable cardioverter-defibrillators: a long-term view. Intern Med J (2012) 0.79

Ethical and legal perspective of implantable cardioverter defibrillator deactivation or implantable cardioverter defibrillator generator replacement in the elderly. Curr Opin Cardiol (2013) 0.78

Age differences in primary prevention implantable cardioverter-defibrillator use in U.S. individuals. J Am Geriatr Soc (2011) 0.78

Safety and effectiveness of primary prevention cardioverter defibrillators in octogenarians. Pacing Clin Electrophysiol (2011) 0.78